209 related articles for article (PubMed ID: 11583861)
1. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.
Goldstein S; Fagerberg B; Hjalmarson A ; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2001 Oct; 38(4):932-8. PubMed ID: 11583861
[TBL] [Abstract][Full Text] [Related]
2. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
[TBL] [Abstract][Full Text] [Related]
3. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
[TBL] [Abstract][Full Text] [Related]
4. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Wikstrand J; Wedel H; Ghali J; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F
Card Electrophysiol Rev; 2003 Sep; 7(3):264-75. PubMed ID: 14739726
[TBL] [Abstract][Full Text] [Related]
5. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
Herlitz J; Wikstrand J; Denny M; Fenster P; Heywood T; Masszi G; Rasmussen S; Thorgeirsson G; Wachtell K;
J Card Fail; 2002 Feb; 8(1):8-14. PubMed ID: 11862577
[TBL] [Abstract][Full Text] [Related]
6. MERIT-HF mortality and morbidity data.
Hjalmarson A; Fagerberg B
Basic Res Cardiol; 2000; 95 Suppl 1():I98-103. PubMed ID: 11192362
[TBL] [Abstract][Full Text] [Related]
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet; 1999 Jun; 353(9169):2001-7. PubMed ID: 10376614
[TBL] [Abstract][Full Text] [Related]
8. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
[TBL] [Abstract][Full Text] [Related]
9. Metoprolol: a review of its use in chronic heart failure.
Prakash A; Markham A
Drugs; 2000 Sep; 60(3):647-78. PubMed ID: 11030472
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee.
Am J Cardiol; 1997 Nov; 80(9B):54J-58J. PubMed ID: 9375952
[TBL] [Abstract][Full Text] [Related]
11. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
[TBL] [Abstract][Full Text] [Related]
12. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Ghali JK; Dunselman P; Waagstein F; Goldstein S; Gottlieb SS; Deedwania PC; Wikstrand JC
J Card Fail; 2004 Dec; 10(6):452-9. PubMed ID: 15599834
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
[TBL] [Abstract][Full Text] [Related]
14. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
[TBL] [Abstract][Full Text] [Related]
15. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
Gottlieb SS; Fisher ML; Kjekshus J; Deedwania P; Gullestad L; Vitovec J; Wikstrand J;
Circulation; 2002 Mar; 105(10):1182-8. PubMed ID: 11889011
[TBL] [Abstract][Full Text] [Related]
17. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
[TBL] [Abstract][Full Text] [Related]
18. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
Gullestad L; Manhenke C; Aarsland T; Skårdal R; Fagertun H; Wikstrand J; Kjekshus J
Eur J Heart Fail; 2001 Aug; 3(4):463-8. PubMed ID: 11511433
[TBL] [Abstract][Full Text] [Related]
19. Extended-release metoprolol succinate in chronic heart failure.
Tangeman HJ; Patterson JH
Ann Pharmacother; 2003 May; 37(5):701-10. PubMed ID: 12708950
[TBL] [Abstract][Full Text] [Related]
20. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
